Cite
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
MLA
Medhurst, Andrew D., et al. “Structurally Novel Histamine H3 Receptor Antagonists GSK207040 and GSK334429 Improve Scopolamine-Induced Memory Impairment and Capsaicin-Induced Secondary Allodynia in Rats.” Biochemical Pharmacology, vol. 73, no. 8, Apr. 2007, pp. 1182–94. EBSCOhost, https://doi.org/10.1016/j.bcp.2007.01.007.
APA
Medhurst, A. D., Briggs, M. A., Bruton, G., Calver, A. R., Chessell, I., Crook, B., Davis, J. B., Davis, R. P., Foley, A. G., Heslop, T., Hirst, W. D., Medhurst, S. J., Ociepka, S., Ray, A., Regan, C. M., Sargent, B., Schogger, J., Stean, T. O., Trail, B. K., … Wilson, D. M. (2007). Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats. Biochemical Pharmacology, 73(8), 1182–1194. https://doi.org/10.1016/j.bcp.2007.01.007
Chicago
Medhurst, Andrew D, Michael A Briggs, Gordon Bruton, Andrew R Calver, Iain Chessell, Barry Crook, John B Davis, et al. 2007. “Structurally Novel Histamine H3 Receptor Antagonists GSK207040 and GSK334429 Improve Scopolamine-Induced Memory Impairment and Capsaicin-Induced Secondary Allodynia in Rats.” Biochemical Pharmacology 73 (8): 1182–94. doi:10.1016/j.bcp.2007.01.007.